MacDerma™ TA | McKinley Resources Incorporated |
|
MacDerma™ TA (Tranexamic Acid) is a derivative of amino acid lysine that is used for melasma (Dark spots) treatment and post-inflammatory hyper pigmentation. Unlike acids such as lactic and glycolic, tranexamic acid is not considered an exfoliating acid a...view more
MacDerma™ TA (Tranexamic Acid) is a derivative of amino acid lysine that is used for melasma (Dark spots) treatment and post-inflammatory hyper pigmentation. Unlike acids such as lactic and glycolic, tranexamic acid is not considered an exfoliating acid and is safe for all sin types, complexions, and use during pregnancy. In fact, tranexamic acid is less irritating than most dark spot-diminishing ingredients. view less
Compliance Highlights Available
|
|
Mearlmica® Treated SVA | Sun Chemical |
|
Mearlmica® Treated SVA is a specialty performance minerals for color cosmetics and personal care products. It contains Lauroyl Lysine to enhance the tactile properties, long-wear properties, and hyd- rophobicity of certain types of cosmetic formulations.
Compliance Highlights Unavailable
|
|
Nuovo-Proline-16® | McKinley Resources Incorporated |
|
Nuovo-Proline-16®is a C16, C16 carboxyl derivative of the amino acid hydroxyproline. Dipalmitoyl hydroxyproline promotes collagen synthesis and enhances skin tone. Additionally, it is an excellent moisturizer and functions as an antioxidant. Nuovo-Prolin...view more
Nuovo-Proline-16®is a C16, C16 carboxyl derivative of the amino acid hydroxyproline. Dipalmitoyl hydroxyproline promotes collagen synthesis and enhances skin tone. Additionally, it is an excellent moisturizer and functions as an antioxidant. Nuovo-Proline-16® is recommended for anti-wrinkle and skin tightening. Nuovo-Proline-16® is used in facial moisturizers and cleansers, eye creams, body firming lotions, foundations, sunless tanning products, sunscreens, lipsticks and balms, scar treatments, masks, varicose/spider vein treatments, and fragrances. The recommended usage of Nuovo-Proline-16® is 0.1% to 1.0%. view less
Compliance Highlights Available
|